InsiderClue
Insiders · Profile

Parker Geoffrey M.

CHIEF FINANCIAL OFFICER at Allogene Therapeutics · Director at PERRIGO. Filing since 21 Nov 2016. CIK 0001491874

ALLO Allogene Therapeutics, Inc. CHIEF FINANCIAL OFFICER · 4 trades PRGO PERRIGO Co plc Director · 9 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ALLO Allogene Therapeutics, Inc.
2 Feb 2026
CHIEF FINANCIAL OFFICER
Sold at will
24,001
$42.24K
1.9%
PRGO PERRIGO Co plc
12 Nov 2025
Director
Bought
7,500
$106.35K
75.9%
ALLO Allogene Therapeutics, Inc.
21 Oct 2025
CHIEF FINANCIAL OFFICER
Sold at will
36,744
$46.17K
2.8%
PRGO PERRIGO Co plc
18 Aug 2025
Director
Bought
4,375
$100.50K
15.1%
PRGO PERRIGO Co plc
12 May 2025
Director
Bought
3,500
$94.85K
17.3%
ALLO Allogene Therapeutics, Inc.
3 Feb 2025
CHIEF FINANCIAL OFFICER
Sold at will
4,361
$7.54K
0.3%
ALLO Allogene Therapeutics, Inc.
30 Jan 2024
CHIEF FINANCIAL OFFICER
Bought
190
$683.05
0.0%
PRGO PERRIGO Co plc
13 Jun 2023
Director
Bought
10,000
$330.64K
63.0%
PRGO PERRIGO Co plc
6 Mar 2023
Director
Bought
5,000
$190.27K
46.0%
PRGO PERRIGO Co plc
16 Dec 2021
Director
Bought
5,000
$184.27K
85.0%
PRGO PERRIGO Co plc
17 Mar 2021
Director
Bought
2,500
$103.22K
×17
PRGO PERRIGO Co plc
12 Nov 2018
Director
Bought
3,000
$196.06K
120%
PRGO PERRIGO Co plc
21 Nov 2016
Director
Bought
2,500
$221.88K
opened
13 decisions on file.